Evidence map›Paper›PMID 36556272›Full record

ArticleJournal of personalized medicine2022

Prediction of Hemorrhagic Complication after Thrombolytic Therapy Based on Multimodal Data from Multiple Centers: An Approach to Machine Learning and System Implementation.

Shaoguo Cui, Haojie Song, Huanhuan Ren, Xi Wang, Zheng Xie, Hao Wen, Yongmei Li

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Advanced Machine Learning Models for Predicting Post-Thrombolysis Hemorrhagic Transformation in Acute Ischemic Stroke Patients: A Systematic Review and Meta-Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  4. Review
  5. Review
  6. Article
  7. The Reasons for Physicians and Pharmacists' Acceptance of Clinical Support Systems in Saudi Arabia.International journal of environmental research and public health · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Shaoguo CuiSchool of Computer and Information Science, Chongqing Normal University, Chongqing 401331, China.
Haojie SongSchool of Computer and Information Science, Chongqing Normal University, Chongqing 401331, China.ORCID 0000-0001-6538-455X
Huanhuan RenDepartment of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Xi WangSchool of Economics, Peking University, Beijing 100871, China.
Zheng XieSchool of Computer and Information Science, Chongqing Normal University, Chongqing 401331, China.
Hao WenSchool of Computer and Information Science, Chongqing Normal University, Chongqing 401331, China.
Yongmei LiDepartment of Radiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Chongqing Normal University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CNPeking University · CN

Funding

Chongqing Normal University 20XLB004Chongqing Postgraduate Scientific Research Innovation Project CYS22555Chongqing Science and Technology Bureau CSTB2022NSCQ-MSX1206,CSTB2022TFII-OFX0042, cstc2019jscx-mbdxX0061Humanity and Social Science Project of Ministry of Education of China 22A10637019Medical Research Program of the Chongqing National Health Commission and Chongqing Sci-ence and Technology Bureau, China 2021MSXM155National Natural Science Foundation of China 62003065Planning Foundation Project of Chongqing Federation of Social Sciences 2022NDYB119Science and Technology Research Program of Chongqing Municipal Education Commission KJZD-K202200510
6 · The paper itself

Abstract

Hemorrhagic complication (HC) is the most severe complication of intravenous thrombolysis (IVT) in patients with acute ischemic stroke (AIS). This study aimed to build a machine learning (ML) prediction model and an application system for a personalized analysis of the risk of HC in patients undergoing IVT therapy. We included patients from Chongqing, Hainan and other centers, including Computed Tomography (CT) images, demographics, and other data, before the occurrence of HC. After feature engineering, a better feature subset was obtained, which was used to build a machine learning (ML) prediction model (Logistic Regression (LR), Random Forest (RF), Support Vector Machine (SVM), eXtreme Gradient Boosting (XGB)), and then evaluated with relevant indicators. Finally, a prediction model with better performance was obtained. Based on this, an application system was built using the Flask framework. A total of 517 patients were included, of which 332 were in the training cohort, 83 were in the internal validation cohort, and 102 were in the external validation cohort. After evaluation, the performance of the XGB model is better, with an AUC of 0.9454 and ACC of 0.8554 on the internal validation cohort, and 0.9142 and ACC of 0.8431 on the external validation cohort. A total of 18 features were used to construct the model, including hemoglobin and fasting blood sugar. Furthermore, the validity of the model is demonstrated through decision curves. Subsequently, a system prototype is developed to verify the test prediction effect. The clinical decision support system (CDSS) embedded with the XGB model based on clinical data and image features can better carry out personalized analysis of the risk of HC in intravenous injection patients.

Indexed as

clinical decision support systemhemorrhagic complicationmachine learningXGB

Identifiers

PMID36556272
PMCPMC9782609
OpenAlexW4311318068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.